Outcomes of Patients with Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Matched Unrelated Donors Compared with One Human Leukocyte Antigen Mismatched Related Donors Using HLA Typing at 10 Loci

Podobne zapisy

• Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion
  od: Oran, Betül, i wsp.
  Wydane: (2018)
• Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis
  od: Yosra M. Aljawai, i wsp.
  Wydane: (2025-08-01)
• Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease
  od: Parmar, Simrit, i wsp.
  Wydane: (2009)
• Can a Female Donor for a Male Recipient Decrease Relapse Rate for Patients with AML Treated with Allogeneic Hematopoietic Stem Cell Transplantation?
  od: Kongtim, Piyanuch, i wsp.
  Wydane: (2014)
• Cytogenetics, Donor Type and use of Hypomethylating Agents in Myelodysplastic Syndrome with Allogeneic Stem Cell Transplantation
  od: Oran, Betul, i wsp.
  Wydane: (2014)